SoftGenetics and 454 Life Sciences, a Roche subsidiary, have entered into a co-promotion agreement designed to provide users of 454 Sequencing Systems with the sequencing data analysis options provided by SoftGenetics’ NextGENe software.
NextGENe software is a free standing biologist-friendly software multi-package that is fully compatibility with 454 Sequencing data for a wide variety of applications, including targeted amplicon resequencing, exome sequencing, transcriptome sequencing, forensic profiling and more. The software package provides additional options for users of 454 Sequencing Systems, in addition to the extensive GS Data Analysis Software suite provided with the platforms.
"This agreement permits both 454 and SoftGenetics the opportunity to more fully understand and address the rapidly changing needs of the NGS marketplace," said SoftGenetics co-founder John Fosnacht. "SoftGenetics welcomes the opportunity to work closely with our colleagues at 454 Life Sciences to provide our mutual customers with integrated sequencing and analysis systems that not only delivers the required quality and sensitivity, but also the efficiency needed in today's scientific and economic environments."
SoftGenetics offers 30-day trials and no cost web-based training on its genetic analysis software packages.